Tomáš Minařík

A multicenter phase II study of the cryptophycin analog LY355703 in patients with platinum-resistant ovarian cancer

Giuseppe Roberto D’Agostino, J. Del Campo, Begoña Mellado et al. · International Journal of Gynecological Cancer · 2006 · 83 citations

Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer

Isabelle Ray‐Coquard, David Cibula, Mansoor Raza Mirza et al. · International Journal of Cancer · 2019 · 58 citations · Full text

A phase II study of gemcitabine plus carboplatin in platinum-sensitive, recurrent ovarian carcinoma

Mehmet Faruk Köse, Jozef Šufliarský, S. Beslija et al. · Gynecologic Oncology · 2004 · 32 citations

Malignant Disease, Medicine, Recurrent Ovarian Carcinoma +7

Prognostic value of various subtypes of extracellular DNA in ovarian cancer patients

Katarína Kaľavská, Tomáš Minařík, Barbora Vlková et al. · Journal of Ovarian Research · 2018 · 29 citations · Full text

Tor does not stink: Use and abuse of the Tor anonymity network from the perspective of law

Tomáš Minařík, Anna-Maria Osula · Computer law & security review · 2015 · 18 citations

Tor Anonymity Network, Engineering, Information Security +12